• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

杂环-2-羧酸（3-氰基-1,4-二-N-氧化物喹喔啉-2-基）酰胺衍生物作为被忽视疾病药物开发的先导化合物。

Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.

作者信息

Ancizu Saioa, Moreno Elsa, Torres Enrique, Burguete Asunción, Pérez-Silanes Silvia, Benítez Diego, Villar Raquel, Solano Beatriz, Marín Adoración, Aldana Ignacio, Cerecetto Hugo, González Mercedes, Monge Antonio

机构信息

Unidad en Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada, University of Navarra, C/Irunlarrea s/n, 31008 Pamplona, Spain.

出版信息

Molecules. 2009 Jun 22;14(6):2256-72. doi: 10.3390/molecules14062256.

DOI:10.3390/molecules14062256
PMID:19553897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6254273/
Abstract

Neglected diseases represent a major health problem. It is estimated that one third of the world population is infected with tuberculosis (TB). Besides TB, Chagas disease, affects approximately 20 million people. Quinoxalines display great activities against TB and Chagas. Forty new quinoxaline 1,4-di-N-oxide derivatives have been prepared and tested against M. tuberculosis and T. cruzi. Carboxylic acid quinoxaline 1,4-di-N-oxides (CAQDOs) 5 and 17 showed MIC values on the same order as the reference antituberculosis drug, rifampicin. Meanwhile, CAQDOs 12 and 22 presented IC(50) values in the same order as the anti-chagasic drug, nifurtimox.

摘要

被忽视的疾病是一个重大的健康问题。据估计，世界三分之一的人口感染了结核病（TB）。除了结核病，恰加斯病影响着约2000万人。喹喔啉对结核病和恰加斯病显示出强大的活性。已经制备了40种新的喹喔啉1,4 - 二氮氧化物衍生物，并针对结核分枝杆菌和克氏锥虫进行了测试。羧酸喹喔啉1,4 - 二氮氧化物（CAQDOs）5和17的最低抑菌浓度（MIC）值与抗结核药物利福平处于同一水平。同时，CAQDOs 12和22的半数抑制浓度（IC50）值与抗恰加斯病药物硝呋替莫处于同一水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/6254273/df28448457b2/molecules-14-02256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/6254273/06336306a62d/molecules-14-02256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/6254273/df28448457b2/molecules-14-02256-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/6254273/06336306a62d/molecules-14-02256-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d07/6254273/df28448457b2/molecules-14-02256-g002.jpg

相似文献

1
Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.杂环-2-羧酸（3-氰基-1,4-二-N-氧化物喹喔啉-2-基）酰胺衍生物作为被忽视疾病药物开发的先导化合物。
Molecules. 2009 Jun 22;14(6):2256-72. doi: 10.3390/molecules14062256.
2
New 3-methylquinoxaline-2-carboxamide 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents.新型 3-甲基喹喔啉-2-甲酰胺 1,4-二-N-氧化物衍生物作为抗结核分枝杆菌药物。
Bioorg Med Chem. 2010 Apr 1;18(7):2713-9. doi: 10.1016/j.bmc.2010.02.024. Epub 2010 Feb 20.
3
Quinoxaline and quinoxaline-1,4-di-N-oxides: An emerging class of antimycobacterials.喹喔啉和喹喔啉-1,4-二-N-氧化物：一类新兴的抗分枝杆菌药物。
Arch Pharm (Weinheim). 2018 May;351(5):e1700325. doi: 10.1002/ardp.201700325. Epub 2018 Apr 3.
4
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.喹喔啉1,4 - 二氧化物的酮和酰胺衍生物的体外和体内抗分枝杆菌活性
J Antimicrob Chemother. 2008 Sep;62(3):547-54. doi: 10.1093/jac/dkn214. Epub 2008 May 23.
5
Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.新型2-喹喔啉甲腈1,4-二氧化物的合成及其抗结核活性
Pharmazie. 1999 Jan;54(1):24-5.
6
Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.新型喹喔啉-2-甲酰胺 1,4-二-N-氧化物衍生物的合成及抗分枝杆菌活性。
Eur J Med Chem. 2010 Oct;45(10):4418-26. doi: 10.1016/j.ejmech.2010.06.036. Epub 2010 Jul 3.
7
Anti- Activity of Esters of Quinoxaline 1,4-Di--Oxide.[喹喔啉 1,4-二--氧化物的酯的抗活性]。
Molecules. 2018 Jun 15;23(6):1453. doi: 10.3390/molecules23061453.
8
Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.喹喔啉 1,4-二氧化物衍生物作为抗结核药物的合成、3D-QSAR 分析及生物学评价
Bioorg Med Chem Lett. 2016 Aug 15;26(16):4146-53. doi: 10.1016/j.bmcl.2016.01.066. Epub 2016 Jan 22.
9
Discovery of novel nitrogenous heterocyclic-containing quinoxaline-1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages.发现新型含氮杂环喹喔啉-1,4-二 N-氧化物作为有效的自噬激活剂，可用于 M.tb 感染的巨噬细胞。
Eur J Med Chem. 2021 Nov 5;223:113657. doi: 10.1016/j.ejmech.2021.113657. Epub 2021 Jun 17.
10
New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.用于治疗结核病的新型喹喔啉 1,4 - 二氧化物
Arzneimittelforschung. 1999 Jan;49(1):55-9. doi: 10.1055/s-0031-1300359.

引用本文的文献

1
-Cyanoacrylamides and 5-Imino Pyrrolones against : Activity and Induced Mechanisms of Cell Death.氰基丙烯酰胺和5-亚氨基吡咯酮对……的作用：细胞死亡活性及诱导机制
Trop Med Infect Dis. 2024 Aug 24;9(9):191. doi: 10.3390/tropicalmed9090191.
2
Dual Antitubercular and Antileishmanial Profiles of Quinoxaline Di--Oxides Containing an Amino Acidic Side Chain.含氨基酸侧链的喹喔啉二氧化物的双重抗结核和抗利什曼原虫特性
Pharmaceuticals (Basel). 2024 Apr 11;17(4):487. doi: 10.3390/ph17040487.
3
Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development.

本文引用的文献

1
QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents.喹喔啉 -2- 羧酸 1,4 - 二 -N - 氧化物作为抗分枝杆菌药物的定量构效关系分析
J Mol Graph Model. 2009 Aug;28(1):28-36. doi: 10.1016/j.jmgm.2009.03.004. Epub 2009 Mar 31.
2
New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.新型强效咪唑并异喹啉酮衍生物作为抗克氏锥虫药物：生物学评价及构效关系
Bioorg Med Chem. 2009 Feb 15;17(4):1437-44. doi: 10.1016/j.bmc.2009.01.011. Epub 2009 Jan 15.
3
Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
喹喔啉 1,4-二氧化物：化学与化疗药物开发进展
Pharmaceuticals (Basel). 2023 Aug 17;16(8):1174. doi: 10.3390/ph16081174.
4
Cyanomethyl Vinyl Ethers Against .氰基甲基乙烯基醚对抗 ……
ACS Chem Neurosci. 2023 Jun 7;14(11):2123-2133. doi: 10.1021/acschemneuro.3c00110. Epub 2023 May 11.
5
In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di--oxide Derivatives against as Trypanothione Reductase Inhibitors.新型 n-丁基和异丁基喹喔啉-7-羧酸 1,4-二--氧化物衍生物抗 作为 硫醇还原酶抑制剂的体外和计算分析。
Int J Mol Sci. 2022 Nov 1;23(21):13315. doi: 10.3390/ijms232113315.
6
Voltammetric Study of Some 3-Aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide Derivatives with Anti-Tumor Activities.伏安法研究具有抗肿瘤活性的一些 3-芳基-喹喔啉-2-甲腈 1,4-二-N-氧化物衍生物。
Molecules. 2017 Aug 31;22(9):1442. doi: 10.3390/molecules22091442.
7
Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase Inhibitors.喹喔啉 1,4-二氧化物衍生物作为锥虫硫氧还蛋白还原酶抑制剂的杀锥虫活性
Molecules. 2017 Feb 1;22(2):220. doi: 10.3390/molecules22020220.
8
Synthetic Medicinal Chemistry in Chagas' Disease: Compounds at The Final Stage of "Hit-To-Lead" Phase.恰加斯病的合成药物化学：处于“从活性分子到先导化合物”阶段末期的化合物
Pharmaceuticals (Basel). 2010 Mar 25;3(4):810-838. doi: 10.3390/ph3040810.
9
Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions.喹喔啉 1,4-二氮氧化物：生物活性及作用机制
Front Pharmacol. 2016 Mar 21;7:64. doi: 10.3389/fphar.2016.00064. eCollection 2016.
10
In silico studies of quinoxaline-2-carboxamide 1,4-di-n-oxide derivatives as antimycobacterial agents.喹喔啉-2-甲酰胺1,4-二氧化物衍生物作为抗分枝杆菌药物的计算机模拟研究
Molecules. 2014 Feb 21;19(2):2247-60. doi: 10.3390/molecules19022247.
新型喹喔啉 1,4 - 二氮氧化物对结核分枝杆菌的选择性活性。
Bioorg Med Chem. 2009 Jan 1;17(1):385-9. doi: 10.1016/j.bmc.2008.10.086. Epub 2008 Nov 5.
4
Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds.抗克氏锥虫药物：我们对五百多种化合物进行评估的经验。
Mini Rev Med Chem. 2008 Nov;8(13):1355-83. doi: 10.2174/138955708786369528.
5
Study of 5-nitroindazoles' anti-Trypanosoma cruzi mode of action: electrochemical behaviour and ESR spectroscopic studies.5-硝基吲唑抗克氏锥虫作用方式的研究：电化学行为和电子自旋共振光谱研究
Eur J Med Chem. 2009 Apr;44(4):1545-53. doi: 10.1016/j.ejmech.2008.07.018. Epub 2008 Jul 23.
6
Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.喹喔啉-2-羧酸1,4-二氮氧化物衍生物在实验性结核病中的疗效
Antimicrob Agents Chemother. 2008 Sep;52(9):3321-6. doi: 10.1128/AAC.00379-08. Epub 2008 Jul 14.
7
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.喹喔啉1,4 - 二氧化物的酮和酰胺衍生物的体外和体内抗分枝杆菌活性
J Antimicrob Chemother. 2008 Sep;62(3):547-54. doi: 10.1093/jac/dkn214. Epub 2008 May 23.
8
Substitutions of fluorine atoms and phenoxy groups in the synthesis of quinoxaline 1,4-di-N-oxide derivatives.喹喔啉 1,4-二氧化物衍生物合成中氟原子和苯氧基的取代
Molecules. 2008 Jan 18;13(1):86-95. doi: 10.3390/molecules13010086.
9
Pyrimido[1,2-a]quinoxaline 6-oxide and phenazine 5,10-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi.嘧啶并[1,2 - a]喹喔啉6 - 氧化物和吩嗪5,10 - 二氧化物衍生物及相关化合物作为克氏锥虫的生长抑制剂
Eur J Med Chem. 2008 Aug;43(8):1737-41. doi: 10.1016/j.ejmech.2007.10.031. Epub 2007 Nov 4.
10
In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives.
J Med Chem. 2007 Nov 29;50(24):6004-15. doi: 10.1021/jm070604e. Epub 2007 Oct 26.